UOTTAIMCU
ADPT icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Adaptive Biotechnologies ADPT Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,161
Closed -$238K – 425
2026
Q1 		$238K Buy
+17,161
New +$273K 0.03% 128
2025
Q3 		– Sell
-211,518
Closed -$2.46M – 212
2025
Q2 		$2.46M Buy
+211,518
New +$1.92M 0.39% 45

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s ADPT Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 17,161 shares — an estimated $238K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in ADPT in Q2 2025 and held it in 2 quarters. The position peaked at $2.46M in Q2 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 17,161 Adaptive Biotechnologies shares in Q2 2026, an estimated $238K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Adaptive Biotechnologies in Q2 2025 and held it in 2 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Adaptive Biotechnologies position peaked at $2.46M in Q2 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.